CIPLA.NS(CIPLA.NS)
CIPLA.NS
No analyst ratings available
No analyst price targets available for CIPLA.NS
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|
| Revenue Avg | $311.01B | $347.65B | $378.16B | $441.99B |
| Low | $297.77B | $327.03B | $377.77B | $419.27B |
| High | $335.22B | $363.15B | $378.55B | $468.64B |
| EBITDA Avg | $85.21B | $95.25B | $103.61B | $121.10B |
| Low | $81.58B | $89.60B | $103.50B | $114.87B |
| High | $91.84B | $99.50B | $103.71B | $128.40B |
| EBIT Avg | $72.31B | $80.82B | $87.92B | $102.75B |
| Low | $69.23B | $76.03B | $87.82B | $97.47B |
| High | $77.93B | $84.43B | $88.01B | $108.95B |
| Net Income Avg | $41.87B | $51.21B | $57.76B | $87.04B |
| Low | $34.62B | $44.14B | $52.72B | $81.22B |
| High | $47.61B | $57.68B | $67.77B | $93.86B |
| EPS Avg | $51.92 | $64.05 | $72.41 | $107.70 |
| Low | $42.84 | $54.61 | $65.23 | $100.50 |
| High | $58.90 | $71.37 | $83.86 | $116.14 |
| Analysts (Rev / EPS) | 34 / 32 | 35 / 32 | 14 / 11 | 9 / 6 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $75.35B | $80.35B | $78.32B |
| Low | $73.74B | $78.64B | $76.65B |
| High | $77.71B | $82.87B | $80.77B |
| EBITDA Avg | $20.64B | $22.01B | $21.46B |
| Low | $20.20B | $21.54B | $21.00B |
| High | $21.29B | $22.70B | $22.13B |
| EBIT Avg | $17.52B | $18.68B | $18.21B |
| Low | $17.14B | $18.28B | $17.82B |
| High | $18.07B | $19.27B | $18.78B |
| Net Income Avg | $10.26B | $11.34B | $10.49B |
| Low | $9.75B | $11.03B | $10.20B |
| High | $10.77B | $11.80B | $10.91B |
| EPS Avg | $12.69 | $14.03 | $12.97 |
| Low | $12.06 | $13.64 | $12.61 |
| High | $13.32 | $14.60 | $13.50 |
| Analysts (Rev / EPS) | 3 / 2 | 2 / 1 | 1 / 1 |